Stocks
News
ETFs
Economy
Currencies
Press Releases
Upstream Bio, Inc. - Common Stock (UPB)
Last Price
5.9950
Change
-0.3050 (-4.84%)
NASDAQ
· Last Trade: Apr 4th, 7:04 PM EDT
Quote
News
Press Releases
Chart
Historical
FAQ
About
Competitors
Discover the 3 Best-Performing Biotech IPO Stocks of 2024
Check out which three biotechnology companies that went public in 2024 and are performing the best and a big factor influenced their rise.
Via
MarketBeat
· November 6, 2024
Upstream Bio Is New On NASDAQ, Can Potentially Beat AstraZeneca's Asthma Drug On Efficacy, Analysts Say
benzinga.com
Upstream Bio garners analyst optimism for its lead drug verekitug, which could disrupt the $7.5 billion asthma biologics market.
Via
Benzinga
· November 5, 2024
This Eaton Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
benzinga.com
Via
Benzinga
· November 5, 2024
Another Trio Of Biotech IPOs Made Friday Debut
talkmarkets.com
The Partners Group-backed KinderCare sold 24 million shares for $24 each this past Tuesday. Meanwhile, a new trio of biotech companies' shares came to market on Friday, as Upstream Bio, CeriBell, and Camp4 Therapeutics each made their public debut.
Via
Talk Markets
· October 13, 2024
